ReviewInfection & chemotherapy2021
HIV-Related Stigma Reduction in the Era of Undetectable Equals Untransmittable: The South Korean Perspective.
Review in Infection & chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Providing 2 Types of mHealth Interventions to Support Self-Management Among People Living With HIV: Randomized Clinical Trial.JMIR mHealth and uHealth · 2025Trial
- Assessment of U = U knowledge and influencing factors among the population in Henan Province China based on an internet-based survey.Scientific reports · 2025Article
- Touch Me Not! Exploring the Devastating Stigma on People Living with HIV.Infection & chemotherapy · 2025Article
- Identifying Health Care Services Offered in the HIV Care Continuum via a Machine Learning-Based Topic Modeling Approach: Exploratory Literature Review.JMIR public health and surveillance · 2025Review
- Aging with HIV: The Burden of Comorbidities, Polypharmacy, and Drug Interactions in Korean People Living with HIV Aged ≥50 Years.Infection & chemotherapy · 2024Article
- Epidemiological Characteristics of HIV-Infected Individuals by the Registration for Special Exempted Calculation: A Nationwide Cohort Study.Infection & chemotherapy · 2024Article
- Epidemiological and Clinical Characteristics of Women Living with HIV in Korea.Infection & chemotherapy · 2024Article
- Addressing HIV stigma in healthcare, community, and legislative settings in Central and Eastern Europe.AIDS research and therapy · 2023Review
- The Story and Implications of the Korean Health Care Facility Counseling Project on People Living with HIV.Infection & chemotherapy · 2023Review
- Implementation of a Nurse-Delivered Cognitive Behavioral Therapy for Adherence and Depression of People Living with HIV in Korea.Infection & chemotherapy · 2022Article
- Three cycles of mobile app design to improve HIV self-management: A development and evaluation study.Digital healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Since the introduction of effective antiretroviral therapy (ART) in the late 1990s, the prognosis for people living with human immunodeficiency virus (HIV) (PLWH) has dramatically improved. High-income countries like South Korea have had rapid declines in HIV-related deaths. Scientific advancements including pre-exposure prophylaxis (PrEP) and "undetectable equals untransmittable (U = U)" knowledge have contributed progress towards the goal of ending the acquired immune deficiency syndrome epidemic by 2030. However, the application of these advancements has been limited in South Korea. Evidence shows that HIV-related stigma and discrimination in healthcare settings remain strong in this region. We review key principles for stigma reduction and people-centered approaches in the era of U = U and identify three priorities: 1) immediate intervention in HIV stigma drivers in healthcare settings; 2) social stigma reduction on multiple levels; and 3) collaboration with key populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.